Cash Flow Orchid Pharma Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
10.00
121.00
89.00
46.00
-1.00
-116.00
Adjustment
41.00
40.00
44.00
51.00
36.00
172.00
Changes In working Capital
70.00
-95.00
-7.00
-79.00
59.00
-36.00
Cash Flow after changes in Working Capital
123.00
66.00
125.00
18.00
94.00
18.00
Cash Flow from Operating Activities
125.00
51.00
125.00
18.00
92.00
23.00
Cash Flow from Investing Activities
-276.00
-36.00
-312.00
-31.00
112.00
67.00
Cash Flow from Financing Activities
137.00
2.00
167.00
31.00
-216.00
-164.00
Net Cash Inflow / Outflow
-14.00
17.00
-19.00
18.00
-11.00
-74.00
Opening Cash & Cash Equivalents
21.00
3.00
22.00
4.00
15.00
89.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
7.00
21.00
3.00
22.00
4.00
15.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Orchid Pharma
Figures in Cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
10.43
184.36
-174.00
-94.34%
Adjustment
41.98
85.04
-44.00
-50.63%
Changes In working Capital
70.88
-17.22
87.00
511.61%
Cash Flow after changes in Working Capital
123.28
252.18
-129.00
-51.11%
Cash Flow from Operating Activities
125.64
214.32
-89.00
-41.38%
Cash Flow from Investing Activities
-276.88
-198.11
-78.00
-39.76%
Cash Flow from Financing Activities
137.14
-29.03
166.00
572.41%
Net Cash Inflow / Outflow
-14.1
-12.82
-2.00
-9.98%
Opening Cash & Cash Equivalents
21.18
78.17
-57.00
-72.91%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
7.07
65.35
-58.00
-89.18%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 144.58% vs -59.23% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
125.64
51.37
144.58%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
